Identification of RUVBL2 as a novel biomarker to predict the prognosis and drug sensitivity in multiple myeloma based on ferroptosis genes
Our study first suggested that RUVBL2 may be regarded as potential therapeutic targets and prognostic value in MM.
Authors
- Sishi Tang
- Xinyi Long
- Siyi Jiang (ORCID: https://orcid.org/0000-0001-8596-2521)
- Yunfeng Fu (ORCID: https://orcid.org/0000-0002-1319-4938)
- Jing Liu (ORCID: https://orcid.org/0000-0002-7366-5287)
- Fangfang Li (ORCID: https://orcid.org/0000-0001-6592-2442)
Institutions
- Central South University (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1080/16078454.2025.2467499
- Citations
- 1
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Natural Science Foundation of China